440 filings
Page 3 of 22
8-K
4038b3oycmoogcjp77
31 Jul 23
Other Events
9:47pm
D
c28ws7saab8v imnjl
28 Jul 23
$10.00 mm in equity / options / securities to be acquired, sold $10.00 mm, 10 investors
2:07pm
8-K
9nolre
21 Jul 23
Entry into a Material Definitive Agreement
8:15am
8-K
zw6z451i58 5ra9s3n
15 Jun 23
Other Events
4:06pm
8-K
oydua
10 May 23
AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:11pm
8-K
cns c4hlz
28 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
UPLOAD
45mdg4dkzadg0cettre
11 Apr 23
Letter from SEC
12:00am
CORRESP
35yi2
11 Apr 23
Correspondence with SEC
12:00am
8-K
48gcu
7 Apr 23
AcelRx Pharmaceuticals Announces Closing of Divestment of DSUVIA® to Alora Pharmaceuticals
3:37pm
8-K
8hbkjxcp 2h
30 Mar 23
AcelRx Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
UPLOAD
jxsfl
30 Mar 23
Letter from SEC
12:00am
8-K
ky4lqbz7o4v c37mil
16 Mar 23
Entry into a Material Definitive Agreement
4:15pm
8-K
l5z498hibvr
29 Dec 22
Other Events
6:03am
424B5
vq7ggyukiw rv6
28 Dec 22
Prospectus supplement for primary offering
5:26pm
8-K
c8p l7js3vlhthlk
5 Dec 22
Termination of a Material Definitive Agreement
5:25pm
EFFECT
4rc5hgq1iq7lkke
23 Nov 22
Notice of effectiveness
12:15am
424B7
ju30xedbq7681fif
22 Nov 22
Prospectus with selling stockholder info
4:29pm